Consistent Legal Evaluation And Regulation of Medical Products Act or the CLEAR Act
This bill requires the Food and Drug Administration to regulate contrast agents for medical imaging devices, radioactive drugs, over-the-counter monograph drugs, and ophthalmic drug articles (i.e., eye droppers) as drugs rather than medical devices.
| Action Date | Type | Text | Source |
|---|---|---|---|
| 2022-05-26 | IntroReferral | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. | Senate |
| 2022-05-26 | IntroReferral | Introduced in Senate | Library of Congress |